MT
MetaVia Inc. (MTVA)
NASDAQ·Healthcare·Biotechnology
$1.41
+28.90%
Mkt Cap $3.17M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.41
+28.90%
Mkt Cap $3.17M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —